CSF CONCENTRATIONS AND SERUM-PROTEIN BINDING OF CARBAMAZEPINE AND CARBAMAZEPINE-10, 11-EPOXIDE IN EPILEPTIC PATIENTS

被引：63
|
作者：
JOHANNESSEN, SI
GERNA, M
BAKKE, J
STRANDJORD, RE
MORSELLI, PL
机构：
[1] NATL HOSP EPILEPSY,N-1300 SANDVIKA,NORWAY
[2] IST RICERCHE FARMACOL M NEGRI,MILANO,ITALY
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1976年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1365-2125.1976.tb04878.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：575 / 582
页数：8
相关论文
共 50 条
  • [41] NO EFFECT OF THIORIDAZINE ON PLASMA-CONCENTRATIONS OF CARBAMAZEPINE AND ITS ACTIVE METABOLITE CARBAMAZEPINE-10,11-EPOXIDE
    SPINA, E
    DAGOSTINO, AMA
    IOCULANO, MP
    OTERI, G
    FAZIO, A
    PISANI, F
    THERAPEUTIC DRUG MONITORING, 1990, 12 (05) : 511 - 513
  • [42] How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples?
    Hermida, J
    Tutor, JC
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 384 - 388
  • [43] INVITRO LYMPHOCYTE-PROLIFERATION BY CARBAMAZEPINE, CARBAMAZEPINE-10, 11-EPOXIDE, AND OXCARBAZEPINE IN THE DIAGNOSIS OF DRUG-INDUCED HYPERSENSITIVITY
    ZAKRZEWSKA, JM
    IVANYI, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (01) : 110 - 115
  • [44] IMPAIRMENT OF CARBAMAZEPINE-10, 11-EPOXIDE ELIMINATION BY VALNOCTAMIDE, A VALPROMIDE ISOMER, IN HEALTHY-SUBJECTS
    PISANI, F
    FAZIO, A
    ARTESI, C
    OTERI, G
    SPINA, E
    TOMSON, T
    PERUCCA, E
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) : 85 - 87
  • [45] A PLS-based extractive spectrophotometric method for simultaneous determination of carbamazepine and carbamazepine-10, 11-epoxide in plasma and comparison with HPLC
    Hemmateenejad, Ahram
    Reazaei, Zahra
    Khabnadideh, Soghra
    Saffari, Maryam
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2007, 68 (03) : 718 - 724
  • [46] Determination of carbamazepine and its metabolite carbamazepine-10,11-epoxide in serum with gas-chromatography mass spectrometry
    Minkova, G
    Getova, D
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (09): : 481 - 485
  • [47] EVALUATION OF EQUATIONS FOR UNBOUND SERUM CONCENTRATION PREDICTION OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE IN POLYTHERAPY PEDIATRIC-PATIENTS WITH EPILEPSY
    KODAMA, Y
    KURANARI, M
    KODAMA, H
    FUJII, I
    TAKEYAMA, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (07) : 835 - 839
  • [48] Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients
    Nakajima, Y
    Saito, Y
    Shiseki, K
    Fukushima-Uesaka, H
    Hasegawa, R
    Ozawa, S
    Sugai, K
    Katoh, M
    Saitoh, O
    Ohnuma, T
    Kawai, M
    Ohtsuki, T
    Suzuki, C
    Minami, N
    Kimura, H
    Goto, Y
    Kamatani, N
    Kaniwa, N
    Sawada, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (01) : 25 - 34
  • [49] Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine
    Bu, HZ
    Kang, P
    Deese, AJ
    Zhao, P
    Pool, WF
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) : 1920 - 1924
  • [50] Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography
    Yoshida, Terumitsu
    Imai, Koichi
    Motohashi, Sumiko
    Hamano, Shin-ichiro
    Sato, Masato
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (04) : 1386 - 1390
12345